+499.5%
MRNA vs DT
+4.0%
+495.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | DT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.6% | -0.6% | -1.8% |
| 7D | +5.5% | -3.3% | +8.8% | +6.3% |
| 30D | +158.7% | +2.0% | +156.7% | +156.4% |
| 3M | +182.1% | +20.0% | +162.1% | +169.2% |
| 6M | +151.8% | +39.3% | +112.5% | +135.5% |
| YTD | +393.6% | +19.8% | +373.8% | +377.6% |
| 1Y | +499.5% | +4.3% | +495.2% | +505.3% |
| All | +499.5% | +4.0% | +495.4% | +505.3% |
Cumulative growth
Daily Returns
Daily percentage return beside DT.
Daily Out/Under-Performance
Portfolio return minus DT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded DT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling